TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
NCT04967430
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
763
Enrollment
OTHER
Sponsor class
Conditions
Sars-CoV2
Covid19
Interventions
DRUG:
Peginterferon Lambda-1A
OTHER:
Placebo
Sponsor
University Health Network, Toronto